Ronan A. Murphy

1.1k total citations · 1 hit paper
17 papers, 550 citations indexed

About

Ronan A. Murphy is a scholar working on Molecular Biology, Molecular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ronan A. Murphy has authored 17 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Molecular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ronan A. Murphy's work include Antibiotic Resistance in Bacteria (6 papers), Bacterial biofilms and quorum sensing (5 papers) and Antimicrobial Peptides and Activities (4 papers). Ronan A. Murphy is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Bacterial biofilms and quorum sensing (5 papers) and Antimicrobial Peptides and Activities (4 papers). Ronan A. Murphy collaborates with scholars based in United Kingdom, Ireland and United States. Ronan A. Murphy's co-authors include E. Fidelma Boyd, Jane C. Davies, Andrew M. Edwards, Akshay Sabnis, Michele Becce, R. Christopher D. Furniss, Gerald Larrouy‐Maumus, Molly M. Stevens, Despoina A. I. Mavridou and Thomas B. Clarke and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Bacteriology.

In The Last Decade

Ronan A. Murphy

17 papers receiving 535 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane

2021 254 citations Akshay Sabnis, Anna Klöckner et al. eLife profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronan A. Murphy United Kingdom	9	215	213	165	138	84	17	550
Wensi S. Hu Taiwan	12	173 0.8×	183 0.9×	111 0.7×	92 0.7×	96 1.1×	26	482
Caressa N. Tsai Canada	12	253 1.2×	173 0.8×	136 0.8×	133 1.0×	77 0.9×	17	551
Bushra Ilyas Canada	4	157 0.7×	186 0.9×	96 0.6×	120 0.9×	53 0.6×	6	434
Aurel Negrea Sweden	10	141 0.7×	153 0.7×	154 0.9×	125 0.9×	75 0.9×	10	495
Gongzheng Hu China	15	146 0.7×	474 2.2×	181 1.1×	129 0.9×	131 1.6×	61	650
R. Christopher D. Furniss United Kingdom	15	291 1.4×	392 1.8×	308 1.9×	93 0.7×	68 0.8×	19	799
Martina Pasqua Italy	13	209 1.0×	236 1.1×	175 1.1×	62 0.4×	57 0.7×	23	525
Yushan Pan China	14	141 0.7×	424 2.0×	152 0.9×	123 0.9×	117 1.4×	46	578
Ashima Kushwaha Bhardwaj India	12	206 1.0×	190 0.9×	184 1.1×	113 0.8×	39 0.5×	15	458
Yongchang Xu China	16	185 0.9×	512 2.4×	155 0.9×	69 0.5×	80 1.0×	37	737

Countries citing papers authored by Ronan A. Murphy

Since Specialization

Citations

This map shows the geographic impact of Ronan A. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronan A. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronan A. Murphy more than expected).

Fields of papers citing papers by Ronan A. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronan A. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronan A. Murphy. The network helps show where Ronan A. Murphy may publish in the future.

Co-authorship network of co-authors of Ronan A. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Ronan A. Murphy. A scholar is included among the top collaborators of Ronan A. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronan A. Murphy. Ronan A. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Murphy, Ronan A., Leah Cuthbertson, Akshay Sabnis, et al.. (2024). Antimicrobial peptide glatiramer acetate targets Pseudomonas aeruginosa lipopolysaccharides to breach membranes without altering lipopolysaccharide modification. PubMed. 2(1). 4–4. 3 indexed citations

Murphy, Ronan A., et al.. (2023). Diversity and prevalence of type VI secretion system effectors in clinical Pseudomonas aeruginosa isolates. Frontiers in Microbiology. 13. 1042505–1042505. 14 indexed citations

King, John A., Ronan A. Murphy, & Jane C. Davies. (2022). Pseudomonas aeruginosa in the Cystic Fibrosis Lung. Advances in experimental medicine and biology. 1386. 347–369. 6 indexed citations

Murphy, Ronan A., Matthew Coates, Akshay Sabnis, et al.. (2022). Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa. Microbiology Spectrum. 10(4). e0081322–e0081322. 6 indexed citations

Okines, Alicia, Benjamin M. Sanderson, Ruth Board, et al.. (2022). A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast Cancer. Clinical Oncology. 34(4). 261–266. 4 indexed citations

Sabnis, Akshay, Anna Klöckner, Michele Becce, et al.. (2021). Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. eLife. 10. 254 indexed citations breakdown →

Murphy, Ronan A., James Harrison, Silke Schelenz, & Jane C. Davies. (2019). M5 The multiple sclerosis drug, glatiramer acetate, acts as a resistance breaker with antibiotics from different classes against cystic fibrosis strains of pseudomonas aeruginosa. A236.3–A237. 1 indexed citations

Murphy, Ronan A., et al.. (2019). P125 The multiple sclerosis drug, glatiramer acetate, acts as a resistance breaker with antibiotics from different classes against cystic fibrosis strains of Pseudomonas aeruginosa. Journal of Cystic Fibrosis. 18. S93–S93. 1 indexed citations

Christiansen, Stig Hill, Ronan A. Murphy, Kristian Juul‐Madsen, et al.. (2017). The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria. Scientific Reports. 7(1). 15653–15653. 25 indexed citations

10.

Turnbull, A R, Amelia Shoemark, Ronan A. Murphy, et al.. (2017). 93 Determining the impact of the T2R38 bitter taste receptor on P. aeruginosa infection in the cystic fibrosis airway. Journal of Cystic Fibrosis. 16. S88–S88. 1 indexed citations

11.

Zhou, Zhemin, A. McCann, Eva Litrup, et al.. (2013). Neutral Genomic Microevolution of a Recently Emerged Pathogen, Salmonella enterica Serovar Agona. PLoS Genetics. 9(4). e1003471–e1003471. 69 indexed citations

12.

Achtman, Mark, James Hale, Ronan A. Murphy, E. Fidelma Boyd, & Steffen Porwollik. (2013). Population structures in the SARA and SARB reference collections of Salmonella enterica according to MLST, MLEE and microarray hybridization. Infection Genetics and Evolution. 16. 314–325. 16 indexed citations

13.

Haase, Jana, et al.. (2012). Transforming Microbial Genotyping: A Robotic Pipeline for Genotyping Bacterial Strains. PLoS ONE. 7(10). e48022–e48022. 15 indexed citations

14.

Haase, Jana, Ronan A. Murphy, Kingshuk Roy Choudhury, & Mark Achtman. (2011). Revival of Seeliger's historical ‘Special Listeria Culture Collection’. Environmental Microbiology. 13(12). 3163–3171. 13 indexed citations

15.

Murphy, Ronan A.. (2009). Transcriptomics based approaches to evaluating and understanding health and nutritional status of poultry.. 153–158. 1 indexed citations

16.

Murphy, Ronan A. & E. Fidelma Boyd. (2007). Three Pathogenicity Islands of Vibrio cholerae Can Excise from the Chromosome and Form Circular Intermediates. Journal of Bacteriology. 190(2). 636–647. 90 indexed citations

17.

Bentley, David W., et al.. (1967). Biotyping, and epidemiological tool for coagulase-negative staphylococci.. PubMed. 7. 54–9. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact